TotalMarketCap

MoonLake Immunotherapeutics

MLTXNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$919.578 M

$10.81 -6.53%

Close of 6 Nov 2026

As of 6 Nov 2026, MoonLake Immunotherapeutics (MLTX) has a market capitalization of $919.6M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$227.3M

Loss-making

Shares outstanding

85,106,685

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #144Janux TherapeuticsJANX$985.5M
  2. #145HarrowHROW$975.1M
  3. #146MoonLake ImmunotherapeuticsMLTX$919.6M
  4. #147SavaraSVRA$896.8M
  5. #148Jade BiosciencesJBIO$896.1M

What if MoonLake Immunotherapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$331,782.09

Per share 30,706× higher

Bitcoin $1.53T

$17,952.15

Per share 1,661× higher

Apple $5.02T

$58,935.24

Per share 5,454× higher

Or at a round number

$2.00B$5.00B$10.0B$20.0B

Where these numbers come from

Share counts and financials for MoonLake Immunotherapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.